CSWYF
Price
$1.00
Change
+$0.07 (+7.53%)
Updated
Jun 3 closing price
Capitalization
519.41M
SNYNF
Price
$99.50
Change
-$2.07 (-2.04%)
Updated
Jun 13 closing price
Capitalization
134.16B
Interact to see
Advertisement

CSWYF vs SNYNF

Header iconCSWYF vs SNYNF Comparison
Open Charts CSWYF vs SNYNFBanner chart's image
China Shineway Pharmaceutical Group
Price$1.00
Change+$0.07 (+7.53%)
Volume$200
Capitalization519.41M
Sanofi
Price$99.50
Change-$2.07 (-2.04%)
Volume$136.31K
Capitalization134.16B
CSWYF vs SNYNF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSWYF vs. SNYNF commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSWYF is a Hold and SNYNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (CSWYF: $1.00 vs. SNYNF: $99.50)
Brand notoriety: CSWYF and SNYNF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CSWYF: 100% vs. SNYNF: 395%
Market capitalization -- CSWYF: $519.41M vs. SNYNF: $134.16B
CSWYF [@Pharmaceuticals: Major] is valued at $519.41M. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSWYF’s FA Score shows that 2 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • CSWYF’s FA Score: 2 green, 3 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, CSWYF is a better buy in the long-term than SNYNF.

Price Growth

CSWYF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was -3.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.36%. For the same industry, the average monthly price growth was +10.48%, and the average quarterly price growth was +8.86%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.36% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

FUNDAMENTALS
Fundamentals
SNYNF($134B) has a higher market cap than CSWYF($519M). SNYNF has higher P/E ratio than CSWYF: SNYNF (14.04) vs CSWYF (9.64). SNYNF YTD gains are higher at: 4.627 vs. CSWYF (0.000). SNYNF has higher annual earnings (EBITDA): 13.8B vs. CSWYF (115M). SNYNF has more cash in the bank: 7.99B vs. CSWYF (643M). CSWYF has less debt than SNYNF: CSWYF (2.93M) vs SNYNF (21B). SNYNF has higher revenues than CSWYF: SNYNF (46.1B) vs CSWYF (457M).
CSWYFSNYNFCSWYF / SNYNF
Capitalization519M134B0%
EBITDA115M13.8B1%
Gain YTD0.0004.627-
P/E Ratio9.6414.0469%
Revenue457M46.1B1%
Total Cash643M7.99B8%
Total Debt2.93M21B0%
FUNDAMENTALS RATINGS
SNYNF: Fundamental Ratings
SNYNF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
75
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSFBX8.78-0.05
-0.57%
Natixis Target Retirement 2015 N
DREYX41.82-0.43
-1.02%
Davis Real Estate Y
JSEAX21.56-0.31
-1.42%
JPMorgan International Equity A
GPGOX3.48-0.06
-1.69%
Grandeur Peak Global Opportunities Inv
HAVLX21.94-0.38
-1.70%
Harbor Large Cap Value Instl

CSWYF and

Correlation & Price change

A.I.dvisor tells us that CSWYF and SCLX have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSWYF and SCLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSWYF
1D Price
Change %
CSWYF100%
N/A
SCLX - CSWYF
7%
Poorly correlated
-7.13%
SNYNF - CSWYF
2%
Poorly correlated
-2.04%
MIRA - CSWYF
1%
Poorly correlated
-2.42%
LYPHF - CSWYF
1%
Poorly correlated
N/A
JCRRF - CSWYF
0%
Poorly correlated
N/A
More

SNYNF and

Correlation & Price change

A.I.dvisor tells us that SNYNF and NVSEF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYNF and NVSEF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
-2.04%
NVSEF - SNYNF
27%
Poorly correlated
+1.00%
BIIB - SNYNF
21%
Poorly correlated
-1.25%
OGN - SNYNF
17%
Poorly correlated
-0.30%
SCLX - SNYNF
7%
Poorly correlated
-7.13%
MIRA - SNYNF
4%
Poorly correlated
-2.42%
More